Skip to content
Tuesday, November 10, 2026
RapidPortal UK

Zimbabwe Turns Down ‘One-Sided’ US Healthcare Assistance Agreement Over Data Fears

Health funding image
The proposed US funding was intended for initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a major American health deal valued at $367m (£272m) spanning five years because of the United States' insistence on sensitive biological samples.

The decision was revealed following a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".

An official spokesperson has since clarified that the US was seeking health data for research and commercial gain while was not willing to share the resulting advantages from future treatments.

"We must now begin the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged continued negotiations to reach a deal suitable to both sides so the country's critical HIV programme can continue.

Wider Context

Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement following concerns were raised about the security of Kenyans' health data.

After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

The agency had managed aid for the American government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and responsibility.

According to reports, Sixteen nations in Africa have so far signed these new agreements, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through American-funded programmes," Tremont added.

However, official spokesman Nick Mangwana argued the proposed deal was "unequal".

"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"Effectively, our nation would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our population if a future disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks already established through the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.

"This mechanism is intended to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," he added.

"We welcome ongoing dialogue with our US partners on how subsequent collaboration might be structured in a manner that honours the sovereignty and interests of both nations."

Medical Community Response

A leading public health body said it recognised the official position, but suggested that negotiations need to persist given that a large portion of the nation's HIV programmes depended on foreign aid.

"Where specific concerns arise, such as those involving information security or implementation frameworks, these can often be resolved via technical clarification and mutually agreed protections," it added.

The halted deal highlights the continuing challenges between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.

AF
About the author

Alicia Fox

A tech strategist with over a decade of experience in digital innovation and business solutions across UK industries.

RapidPortal UK

Type to search articles.